CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Total	Common Stock	Additional Paid in Capital	Retained Earnings (Accumulated Deficit)
Beginning Balances at Dec. 31, 2021	$ 47,118,097	$ 107,086	$ 46,851,360	$ 159,651
Beginning Balance, shares at Dec. 31, 2021		10,708,613
Restricted stock grants issued		$ 260	(260)
Restricted stock grants issued, Shares		26,025
Restricted stock grant forfeitures, shares		(203)
Restricted stock grant forfeiture		$ (2)	2
Issuance of common stock, net of expenses	198,370	$ 659	197,711
Issuance of common stock, net of expenses, Shares		65,843
Stock-based compensation	52,604		52,604
Net income	283,207			283,207
Dividends	(700,339)			(700,339)
Ending Balance at Mar. 31, 2022	46,951,939	$ 108,003	47,101,417	(257,481)
Ending Balance, shares at Mar. 31, 2022		10,800,278
Beginning Balances at Dec. 31, 2022	$ 48,339,114	$ 111,091	49,029,712	(801,689)
Beginning Balance, shares at Dec. 31, 2022	11,109,077	11,109,077
Restricted stock grants issued		$ 380	(380)
Restricted stock grants issued, Shares		37,976
Restricted stock grant forfeitures, shares		(3,145)
Restricted stock grant forfeiture		$ (32)	32
Stock-based compensation	$ 37,787		37,787
Net income	992,541			992,541
Dividends	(805,228)			(805,228)
Ending Balance at Mar. 31, 2023	$ 48,564,214	$ 111,439	$ 49,067,151	$ (614,376)
Ending Balance, shares at Mar. 31, 2023	11,143,908	11,143,908